About Dr. Rajat Bajaj
Dr. Rajat Bajaj is widely recognized as a leading medical oncologist in Delhi, known for his expertise and dedication to advancing cancer care. Dr Bajaj specializes in treatment of solid cancers—such as lung, breast, colorectal, and head & neck—with a focus on immunotherapy, targeted biologics, TKIs, and oral therapies.He averages 700+ immunotherapy treatments annually. As a national-level faculty member, he frequently lectures at oncology conferences.
OPD Schedule Of Dr. Rajat Bajaj
Consultation Fees Rs. 1000 /-
Fortis Hospital, Noida
- MBBS: Maulana Azad Medical College, New Delhi (2008)
- MD (General Medicine): Maulana Azad Medical College, New Delhi (2012)
- DNB – Medical Oncology: Rajiv Gandhi Cancer Institute & Research Centre, Delhi (2018)
- ESMO-certified in Medical Oncology
- Advanced training in immunotherapy (Singapore) and breast cancer (Berlin)
- Breast cancer
- Lung cancer
- GI cancer
- Head & neck cancer
- Prostate cancer
- Gynecologic cancers
- Immunotherapy & Targeted Treatments: Administers 700+ immunotherapy protocols annually
- TKIs & Biologics Delivery: In-depth experience with oral and IV targeted agents
- Director & Unit Head, Medical Oncology, Fortis Hospital Noida (Current)
- Consultant, Medical Oncology – Fortis Escorts Hospital, Faridabad
- Senior Registrar – Rajiv Gandhi Cancer Institute, Delhi
- Indian Achievers Award in Oncology (2021–22)
- Additional recognitions: TSICQ Quiz awards, poster presentations at national meets
- Prognostic role of microRNA‑182 and microRNA‑18a in locally advanced triple negative breast cancer
- Prevalence of HRR mutations in Indian patients with mCRPC
- Praised for his patient-centric care, clarity in communication, and clinical depth “Excellent care—I am in touch with Dr. Bajaj for past one year… very effective treatment plans.”
- “Very pleasant personality with assured smile on face. A patient with cancer gains courage once meeting this doctor. Diagnosis, treatment plan, and guidance were spot‑on.”
- “Treatment plans were very effective. Understands the situation and supports patients accordingly. Happy with the treatment.”
- Advocates a personalized, evidence-driven approach using molecular profiling and genomic insights.
- Promotes multidisciplinary care, involving surgeons, radiologists, geneticists, and palliative teams.
- Emphasizes empathy and patient education in shared decision-making.
Treatment Type | Cost Range Estimate (INR) | Cost Range Estimate (USD) |
Immunotherapy (per cycle, e.g., Pembrolizumab/Nivolumab) | 2,00,000 – 4,50,000 | 2,400 – 5,450 |
Targeted Therapy (oral/IV, per cycle) | 40,000 – 2,50,000 | 480 – 3,000 |
Chemotherapy (standard, per cycle) | 25,000 – 80,000 | 300 – 960 |
Comprehensive Cancer Evaluation (workup, imaging, markers) | 50,000 – 1,50,000 | 600 – 1,800 |
Day Care Services (per session, excl. drugs) | 6,000 – 15,000 | 72 – 180 |
Inpatient Stay (per day, private room) | 7,500 – 16,000 | 90 – 192 |
- Language Support: Cancer Rounds offers multilingual assistance and translation services to support international patients throughout their treatment journey.
- Visa & Travel Assistance: Cancer Rounds provides dedicated support for visas, travel arrangements, and accommodations.
- Pre-treatment Virtual Consultations: International patients can avail of online consultations via Cancer Rounds to review scans and plan their care remotely.